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There has been a dramatic surge in research on 
auditory hallucinations over the past 15 years. Of the 
more than 100 papers identified in a recent meta-
analysis of studies on definition, description and 
causes of auditory hallucinations (1), greater than 90% 
were published since the year 2000. This glut of 
publications points to an upheaval that has taken 
place in psychiatry. Simply put, there has been a 
paradigm shift: a movement away from the 
Schneiderian view of auditory hallucinations as 
(predominantly) symptoms of psychotic disorder, 
towards an increasingly accepted view that these are 
experiences that occur in the full range of mental 
disorders and, indeed, none.   
 
Research on auditory hallucinations was galvanised in 
2000 by the results of the Dunedin study, which 
showed that 11 year olds who reported psychotic 
symptoms (predominantly auditory hallucinations) 
were at increased risk of psychotic disorder at age 26 
(2). As a result of this and subsequent research, 
individuals in the community with psychotic 
symptoms came to be perceived as an epidemiological 
complement to the clinic-based ‘ultra high risk’ 
approach to psychosis (3). Extensive epidemiological 
research since that time has hugely broadened this 
focus to show that individuals who report 
hallucinations are at high risk for a wide range of poor 
outcomes across the whole spectrum of mental 
disorders, but in particular multimorbid (non-
psychotic) mental disorders, suicidality, poor socio-
occupational functioning and neurocognitive deficits 
(4, 5).  
 
The findings that auditory hallucinations in the 
population are far more predictive of affective, 
anxiety and behavioural disorders (and indeed of no 
specific mental disorder) than psychotic disorders, has 
caused a conundrum for clinicians. If these symptoms 
are so non-specific, what (if anything) can we, or 
should we, do about them? In one of the longest 
follow up studies to date Bartels-Velthuis et al found 
that only 18% of children and adolescents with 
auditory hallucinations continued to experience these 
6 years later, and only 6% a decade later (6). This 
demonstrates that hallucinations become a chronic 
problem for only a minority of children when followed 
to adulthood.  
 
Notwithstanding the low persistence rate of 
hallucinations over time, we know that a report of 
auditory hallucinations even at one point in 
adolescence is associated with poor mental health 
outcomes in a substantial proportion of individuals. 
This presents an important opportunity to identify a 
vulnerable group for early intervention. The question, 
then, is how do we improve our identification of the 
specific individuals who are likely to have poor  
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outcomes and how do we differentiate them from 
auditory hallucinations that will take a benign course?  
 
Many clinicians suspect that specific aspects of the 
hallucinations are likely to identify those who are truly 
at risk of poor outcomes, including (but not limited to) 
pathways to psychosis. Just as there are clinical 
features of headache that point to risk of a non-
benign course (e.g., nuchal rigidity and photophobia), 
so too might there be clinical features of hallucinatory 
experiences that would predict a non-benign course– 
be it, for example, phenomenological aspects of the 
experience, degrees of reality testing, associated 
distress or functional impact.  Both in research and in 
the clinic, however, characterisation of these aspects 
of hallucinatory experiences is typically poor and, 
without doubt, is poorly standardised from one site to 
the next. That is despite the fact that we have, in 
psychiatry, a rich descriptive system for hallucinatory 
experiences.  
 
As highlighted by Upthegrove et al. in their recent 
meta-analysis, even when specific psychosis interview 
instruments are used, they take a rather atheoretical 
approach in determining what aspects of 
hallucinations to assess, “without clear evidence that 
these are either the aspects research should be 
focusing on or those which define clinically significant 
experiences from ‘normal’ voice hearing” (1). At 
present, we are ill-equipped to determine the aspects 
of hallucinations on which we should focus. Progress 
on this front is dependent on adopting more 
standardised approaches to assessment (and, 
crucially, clinical documentation) of hallucinations, 
which will facilitate research on the prognostic 
significance of these features. The basis of this must 
be a consistent clinical approach to assessing 
hallucinatory experiences from one site to the next.  
 
It was with the above in mind that we formulated the 
SOCRATES assessment as a means of providing a  
 
straightforward structure for assessing hallucinations 
and unusual thought content  in routine clinical 
settings (7), the idea being to promote a consistent 
assessment across multiple phenomenological and 
clinical/functional domains each time a patient 
reports hallucinations (or unusual thought content). 
The SOCRATES mnemonic prompts the assessor to 
note details on (i) Source or location of hallucinations 
(internal or external space); (ii) Onset, duration and 
frequency of hallucinations, (iii) Character (e.g., 
shouting/whispering, emotional valence) and content 
of the hallucination (e.g., whether in 1st/2nd/3rd 
person, specific examples/themes spoken about etc); 
(iv) Reality testing and Attribution; (iv) Timing (e.g. 
only in the context of drug /alcohol use; only 
hypnopompic/hypnagogic); (v) Effects on functioning 
(including degree of control) and (vi) Severity of 
distress (rated 1-10). See Table 1 for an example. The 
idea is that any clinical assessment of hallucinations or 
unusual thought content should include the above 
details as standard. By taking standardised 
approaches to the assessment of hallucinations, this 
will facilitate research on prognostic significance of 
specific aspects of psychotic experiences both within 
and between services – something sorely lacking from 
clinical research at this point in time. This descriptive 
approach would also help us to move away from the 
simplistic documentation of hallucinations for some 
cases and ‘pseudohallucinations’ for others, a term 
used far too flexibly and which is often chosen 
primarily based on the diagnosis within which the 
symptom arises, rather than any substantive 
difference from perceptual abnormalities experienced 
in schizophrenia. 
 
What to do about auditory hallucinations? 
This all begs the question: what should we do about 
hallucinations when they are reported. Regardless of 
the relatively low rate of persistence over time, for 
many individuals hallucinations are associated with 
distress and/or dysfunction. Although there is a lack of 
clear guidance to direct clinicians, research findings to
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Table 1: Clinical documentation of auditory hallucination using SOCRATES formulation – a practical example 
  
Source External space. 
Onset 
Duration 
Frequency 
2 months ago.  
Average 15mins (range 10mins – 1hour).  
2-3 times per day, 4-5 days per week. No change in frequency since onset. 
Character One voice only. Sounds like a man in his 20s, similar to own accent, but distinct from own voice. Normal volume, rate and tone of 
voice. Emotional valence: negative (“He’s bad”). 
Content 2nd person critical comments, e.g., “Why are you doing it that way; you’re so stupid”. No 1st person, 3rd person, running 
commentary, commands. 
Reality testing and 
Attribution 
“I think it’s someone watching me”. No clear idea of who this might be. Reality testing intact when directly challenged: 70% 
‘someone watching me’ vs 30% ‘my imagination playing tricks on me’. 
Timing Mainly hears voice when he is alone. Not hypnagogic/hypnopompic. No alcohol, substances, febrile illness. 
Effects on functioning Has locked himself in his bedroom to try to ‘escape’ the voice. Has responded to the voice out loud (“Shut up!”). Does not feel the 
voice has any control over him. 
Severity of distress 9/10 
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date point to a number of approaches that can benefit 
help seekers.                                 
1. Demystify and destigmatise. Individuals are 
typically well aware that their experiences are socially 
unacceptable and that to disclose them would invite 
scorn or fear. This adds greatly to the burden of 
coping with these experiences; indeed, in many cases, 
much of the distress relates to anxiety that these 
symptoms are harbingers of doom – ‘I’m going mad!’ 
– as opposed to distress around the experience itself 
(to quote Hermione in Harry Potter and the Chamber 
of Secrets, “Even in the wizarding world, hearing 
voices isn’t a good sign”). In this context, it is not 
surprising that the clinician who directly asks about 
perceptual abnormalities is often the very first person 
to be told about them. An unflappable reaction to 
such a disclosure can prove therapeutic in and of 
itself. Psychoeducation helps to decatastrophise the 
experiences by highlighting how prevalent these 
experiences are (5-7% of the general adult population 
report them), especially given that the patient’s 
perception of an individual who ‘hears voices’ is often 
based on sensational portrayals of schizophrenia in 
film. “It does not mean you’re going mad” can prove a 
very therapeutic phrase.  
2. Assess for and treat all mental disorders. 
Hallucinations are associated with a wide range of 
mental disorders but are especially predictive of 
multimorbid psychopathology – that is, having more 
than one mental disorder (4). It is important to 
identify and treat all disorders. In many cases, as any 
co-occurring mental disorders improve, so too do 
hallucinations. 
3. Identify ongoing traumatic experiences. We 
previously demonstrated that individuals who 
experienced physical assaults had a high risk of 
auditory hallucinations. However, individuals for 
whom these assaultative experiences ceased 
demonstrated a marked decline in prevalence of 
hallucinations at follow up assessment. Individuals for 
whom assaultative experiences persisted, on the  
 
 
other hand, maintained or increased their prevalence 
of hallucinations (8). The same effect was 
demonstrated for cessation of bullying. There is often 
a lot of shame for individuals with abusive 
experiences, which hinders their willingness to report 
them. Therefore, the clinician has an important role to 
play in eliciting traumatic experiences and, wherever 
possible, acting to prevent further occurrences. Just as 
respiratory physicians address the importance of 
smoking cessation to prevent lung disease, so too 
should psychiatrists be ready to acknowledge and 
address trauma as a major environmental risk for 
mental ill health. 
4. Advise patients on other modifiable risk factors, 
most notably drug use. Patients should be advised of 
the psychotogenic risks associated with cannabis (and 
other substances), including the risk of transient 
hallucinations becoming a chronic condition. It is likely 
that individuals who experience hallucinations are at 
particular risk from substances and, therefore, 
unambiguous advice on abstinence from drugs is an 
important clinical message.  
 
Where to from here? 
There has been an upheaval in our understanding of 
hallucinations in modern psychiatry. Far from being 
predominantly symptoms of psychosis, these are 
experiences that occur in the full range of mental 
disorders and, indeed, none. In light of extensive 
research over the past 15 years, the very idea of 
terming these experiences ‘psychotic’ is questionable, 
occurring, as they do, much more frequently in the 
context of ‘neurotic’ (or even no) disorder. A greater 
emphasis on clinical research (using core psychiatric 
skills, such as phenomenological investigation) will 
help to determine if clinical features of these 
experiences predict pathways to psychosis and other 
poor outcomes, as opposed to cases where these 
experiences run a relatively benign course. Greater 
standardisation of assessments from one clinical site 
to the next is needed if we are to succeed in this work.  
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